Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quantification of Physical Activity After Corticosteroid Injection in Knee OA
NCT02049879Phase 4Completed
- Sponsor
- Université Laval
- Start
- Nov 2008
- Primary completion
- Aug 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of triamcinolone in knee osteoarthritis (OA), sponsored by Université Laval. Primary endpoints: Change in Knee pain at 6 weeks and Change in physical activity at 6 weeks. Started Nov 2008; status: completed.
02
Drugs
triamcinolone
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02049879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02049879.